Renato Sablich

780 total citations
19 papers, 466 citations indexed

About

Renato Sablich is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Renato Sablich has authored 19 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Renato Sablich's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (2 papers). Renato Sablich is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (2 papers). Renato Sablich collaborates with scholars based in Italy and United Kingdom. Renato Sablich's co-authors include Teresa Lacchin, P. Ravelli, G Lapertosa, Mássimo Conio, R Ferraris, Gaetano Iaquinto, Sabrina Blanchi, Rosangela Filiberti, Santino Marchi and Giorgio Benedetti and has published in prestigious journals such as Scientific Reports, International Journal of Cancer and The American Journal of Gastroenterology.

In The Last Decade

Renato Sablich

17 papers receiving 451 citations

Peers

Renato Sablich
Renato Sablich
Citations per year, relative to Renato Sablich Renato Sablich (= 1×) peers Xiaorong Gong

Countries citing papers authored by Renato Sablich

Since Specialization
Citations

This map shows the geographic impact of Renato Sablich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Sablich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Sablich more than expected).

Fields of papers citing papers by Renato Sablich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Sablich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Sablich. The network helps show where Renato Sablich may publish in the future.

Co-authorship network of co-authors of Renato Sablich

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Sablich. A scholar is included among the top collaborators of Renato Sablich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Sablich. Renato Sablich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bertin, Luisa, Brigida Barberio, Lorenzo Bertani, et al.. (2024). Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn’s Disease. Journal of Clinical Medicine. 13(6). 1539–1539. 3 indexed citations
2.
Sablich, Renato, et al.. (2023). Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis. Scientific Reports. 13(1). 1816–1816. 7 indexed citations
3.
Campigotto, Michele, et al.. (2022). Childbearing and Delivery in Women With Ulcerative Colitis and Ileostomy or Ileal Pouch-Anal Anastomosis. ACG Case Reports Journal. 9(6). e00805–e00805. 2 indexed citations
4.
Campigotto, Michele, et al.. (2021). AF.66 VEDOLIZUMAB INDUCED LIVER INJURY: A RARE BUT MEANINGFUL CONDITION. Digestive and Liver Disease. 53. S167–S167.
5.
Colombo, A., Mauro Giuffrè, Lory Saveria Crocè, Sergio Venturini, & Renato Sablich. (2021). Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test. Pathogens. 10(5). 535–535. 2 indexed citations
6.
Barberio, Brigida, Cristina Canova, Giulia Barbieri, et al.. (2021). A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study. Therapeutic Advances in Gastroenterology. 14. 1088214396–1088214396. 18 indexed citations
7.
Barberio, Brigida, Fabiana Zingone, R. D’Incà, et al.. (2020). P415 The anti-IL-23/IL-12 agent Ustekinumab is an effective and safe induction therapy in patients with Crohn’s disease refractory or intolerant to anti-TNF: a multicentre Italian study. Journal of Crohn s and Colitis. 14(Supplement_1). S379–S379. 2 indexed citations
8.
Daperno, Marco, Aurora Bortoli, Anna Kohn, et al.. (2017). Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study. Digestive and Liver Disease. 49(9). 997–1002. 7 indexed citations
9.
Balzano, A., Francesco Manguso, Vito Annese, et al.. (2010). P.227 ORAL TREATMENT OF MILD TO MODERATE ULCERATIVE COLITIS WITH BECLOMETHASONE DIPROPIONATE OR PREDNISONE. A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL. Digestive and Liver Disease. 42. S181–S181. 1 indexed citations
10.
Saibeni, Simone, R. D’Incà, Luisa Spina, et al.. (2008). The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Digestive and Liver Disease. 40(10). 814–820. 36 indexed citations
11.
Conio, Mássimo, Sabrina Blanchi, G Lapertosa, et al.. (2003). Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study. The American Journal of Gastroenterology. 98(9). 1931–1939. 163 indexed citations
12.
Conio, Mássimo, Rosangela Filiberti, Sabrina Blanchi, et al.. (2001). Risk factors for Barrett's esophagus: A case‐control study. International Journal of Cancer. 97(2). 225–229. 113 indexed citations
13.
Pozzato, Gabriele, Michele Moretti, F. Franzin, et al.. (1995). Ethanol Metabolism and Aging: The Role of "First Pass Metabolism" and Gastric Alcohol Dehydrogenase Activity. The Journals of Gerontology Series A. 50A(3). B135–B141. 53 indexed citations
14.
Pozzato, Gabriele, F. Franzin, Michéle Moretti, et al.. (1994). Effects of omeprazole on ethanol metabolism: an in vitro and in vivo rat and human study. Pharmacological Research. 29(1). 47–58. 10 indexed citations
15.
Benedetti, Giorgio, Renato Sablich, & Teresa Lacchin. (1991). Endoscopic injection sclerotherapy in non-variceal upper gastrointestinal bleeding. Surgical Endoscopy. 5(1). 28–30. 18 indexed citations
16.
Sablich, Renato, et al.. (1991). Fiberoptic endoscopic resection of symptomatic leiomyoma of the upper esophagus. Case report.. PubMed. 156(11-12). 807–8. 2 indexed citations
17.
Sablich, Renato, et al.. (1991). [Environmental risk factors in the pathogenesis of peptic ulcer. The role of cigarette smoke].. PubMed. 36(2). 99–103. 1 indexed citations
18.
Sablich, Renato, et al.. (1988). Squamous Cell Papilloma of the Esophagus Report on 35 Endoscopic Cases. Endoscopy. 20(1). 5–7. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026